Literature DB >> 25887293

Loss of mTOR signaling affects cone function, cone structure and expression of cone specific proteins without affecting cone survival.

Shan Ma1, Aditya Venkatesh2, Fernanda Langellotto3, Yun Z Le4, Michael N Hall5, Markus A Rüegg6, Claudio Punzo7.   

Abstract

Cones are the primary photoreceptor (PR) cells responsible for vision in humans. They are metabolically highly active requiring phosphoinositide 3-kinase (PI3K) activity for long-term survival. One of the downstream targets of PI3K is the kinase mammalian target of rapamycin (mTOR), which is a key regulator of cell metabolism and growth, integrating nutrient availability and growth factor signals. Both PI3K and mTOR are part of the insulin/mTOR signaling pathway, however if mTOR is required for long-term PR survival remains unknown. This is of particular interest since deregulation of this pathway in diabetes results in reduced PR function before the onset of any clinical signs of diabetic retinopathy. mTOR is found in two distinct complexes (mTORC1 & mTORC2) that are characterized by their unique accessory proteins RAPTOR and RICTOR respectively. mTORC1 regulates mainly cell metabolism in response to nutrient availability and growth factor signals, while mTORC2 regulates pro-survival mechanisms in response to growth factors. Here we analyze the effect on cones of loss of mTORC1, mTORC2 and simultaneous loss of mTORC1 & mTORC2. Interestingly, neither loss of mTORC1 nor mTORC2 affects cone function or survival at one year of age. However, outer and inner segment morphology is affected upon loss of either complex. In contrast, concurrent loss of mTORC1 and mTORC2 leads to a reduction in cone function without affecting cone viability. The data indicates that PI3K mediated pro-survival signals diverge upstream of both mTOR complexes in cones, suggesting that they are independent of mTOR activity. Furthermore, the data may help explain why PR function is reduced in diabetes, which can lead to deregulation of both mTOR complexes simultaneously. Finally, although mTOR is a key regulator of cell metabolism, and PRs are metabolically highly active, the data suggests that the role of mTOR in regulating the metabolic transcriptome in healthy cones is minimal.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Cone survival; Diabetic retinopathy; Neuroprotective; PI3K; Photoreceptors; Retinitis pigmentosa; Visual function; mTOR

Mesh:

Substances:

Year:  2015        PMID: 25887293      PMCID: PMC4446177          DOI: 10.1016/j.exer.2015.04.006

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  62 in total

1.  Myopathy caused by mammalian target of rapamycin complex 1 (mTORC1) inactivation is not reversed by restoring mitochondrial function.

Authors:  Klaas Romanino; Laetitia Mazelin; Verena Albert; Agnès Conjard-Duplany; Shuo Lin; C Florian Bentzinger; Christoph Handschin; Pere Puigserver; Francesco Zorzato; Laurent Schaeffer; Yann-Gaël Gangloff; Markus A Rüegg
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-05       Impact factor: 11.205

2.  Photoreceptor transplants increase host cone survival in the retinal degeneration (rd) mouse.

Authors:  S Mohand-Said; D Hicks; M Simonutti; D Tran-Minh; A Deudon-Combe; H Dreyfus; M S Silverman; J M Ogilvie; T Tenkova; J Sahel
Journal:  Ophthalmic Res       Date:  1997       Impact factor: 2.892

3.  Activated mTORC1 promotes long-term cone survival in retinitis pigmentosa mice.

Authors:  Aditya Venkatesh; Shan Ma; Yun Z Le; Michael N Hall; Markus A Rüegg; Claudio Punzo
Journal:  J Clin Invest       Date:  2015-03-23       Impact factor: 14.808

4.  Differential effect of the rd mutation on rods and cones in the mouse retina.

Authors:  L D Carter-Dawson; M M LaVail; R L Sidman
Journal:  Invest Ophthalmol Vis Sci       Date:  1978-06       Impact factor: 4.799

5.  Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy.

Authors:  C Florian Bentzinger; Klaas Romanino; Dimitri Cloëtta; Shuo Lin; Joseph B Mascarenhas; Filippo Oliveri; Jinyu Xia; Emilio Casanova; Céline F Costa; Marijke Brink; Francesco Zorzato; Michael N Hall; Markus A Rüegg
Journal:  Cell Metab       Date:  2008-11       Impact factor: 27.287

Review 6.  The biology of cancer: metabolic reprogramming fuels cell growth and proliferation.

Authors:  Ralph J DeBerardinis; Julian J Lum; Georgia Hatzivassiliou; Craig B Thompson
Journal:  Cell Metab       Date:  2008-01       Impact factor: 27.287

7.  Enhanced retinal insulin receptor-activated neuroprotective survival signal in mice lacking the protein-tyrosine phosphatase-1B gene.

Authors:  Raju V S Rajala; Masaki Tanito; Benjamin G Neel; Ammaji Rajala
Journal:  J Biol Chem       Date:  2010-01-08       Impact factor: 5.157

8.  Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosa.

Authors:  Claudio Punzo; Karl Kornacker; Constance L Cepko
Journal:  Nat Neurosci       Date:  2008-12-07       Impact factor: 24.884

9.  Diabetes reduces autophosphorylation of retinal insulin receptor and increases protein-tyrosine phosphatase-1B activity.

Authors:  Raju V S Rajala; Brandt Wiskur; Masaki Tanito; Michelle Callegan; Ammaji Rajala
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-11-21       Impact factor: 4.799

10.  Electrophysiological measurement of the number of rhodopsin molecules in single Limulus photoreceptors.

Authors:  J E Lisman; H Bering
Journal:  J Gen Physiol       Date:  1977-11       Impact factor: 4.086

View more
  14 in total

Review 1.  The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapy.

Authors:  Dimitra Athanasiou; Monica Aguila; James Bellingham; Wenwen Li; Caroline McCulley; Philip J Reeves; Michael E Cheetham
Journal:  Prog Retin Eye Res       Date:  2017-10-16       Impact factor: 21.198

2.  Mitochondria: The Retina's Achilles' Heel in AMD.

Authors:  Deborah A Ferrington; M Cristina Kenney; Shari R Atilano; James B Hurley; Emily E Brown; John D Ash
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Mechanism of Cone Degeneration in Retinitis Pigmentosa.

Authors:  De-Juan Song; Xiao-Li Bao; Bin Fan; Guang-Yu Li
Journal:  Cell Mol Neurobiol       Date:  2022-07-06       Impact factor: 5.046

4.  Loss of the cone-enriched caspase-7 does not affect secondary cone death in retinitis pigmentosa.

Authors:  Aditya Venkatesh; Shun-Yun Cheng; Claudio Punzo
Journal:  Mol Vis       Date:  2017-12-15       Impact factor: 2.367

5.  Adeno-Associated Viral Vector-Mediated mTOR Inhibition by Short Hairpin RNA Suppresses Laser-Induced Choroidal Neovascularization.

Authors:  Tae Kwann Park; Si Hyung Lee; Jun Sub Choi; Seung Kwan Nah; Hee Jong Kim; Ha Yan Park; Heuiran Lee; Steven Hyun Seung Lee; Keerang Park
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-01       Impact factor: 8.886

6.  Aerobic Glycolysis Is Essential for Normal Rod Function and Controls Secondary Cone Death in Retinitis Pigmentosa.

Authors:  Lolita Petit; Shan Ma; Joris Cipi; Shun-Yun Cheng; Marina Zieger; Nissim Hay; Claudio Punzo
Journal:  Cell Rep       Date:  2018-05-29       Impact factor: 9.423

7.  Improved cell metabolism prolongs photoreceptor survival upon retinal-pigmented epithelium loss in the sodium iodate induced model of geographic atrophy.

Authors:  Marina Zieger; Claudio Punzo
Journal:  Oncotarget       Date:  2016-03-01

8.  mTORC1 sustains vision in retinitis pigmentosa.

Authors:  Lolita Petit; Claudio Punzo
Journal:  Oncotarget       Date:  2015-07-10

9.  TSC but not PTEN loss in starving cones of retinitis pigmentosa mice leads to an autophagy defect and mTORC1 dissociation from the lysosome.

Authors:  A Venkatesh; S Ma; C Punzo
Journal:  Cell Death Dis       Date:  2016-06-30       Impact factor: 8.469

Review 10.  Metabolic and redox signaling in the retina.

Authors:  Thierry Léveillard; José-Alain Sahel
Journal:  Cell Mol Life Sci       Date:  2016-08-20       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.